Search
« U.K.’s Voluntary Scheme For Branded Medicines, Pricing, And Access (VPAS) Faces A Potential Crisis
The ‘KHN Health Minute’ Debuts on CBS News Radio »
Forbes, healthcare, pharma
January 20, 2023
by Bruce Y. Lee, Senior Contributor